Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-02 Thompson Peter A. Director Grant or award · Stock option (right to buy) +16,333 16,333
2020-09-29 Thompson Peter A. Director Conversion +4,025,076 4,500,076
2020-09-29 Thompson Peter A. Director Conversion +1,076,891 5,576,967
2020-09-29 Thompson Peter A. Director Conversion +518,191 6,095,158
2020-09-29 Thompson Peter A. Director Conversion +380,133 6,475,291
2020-09-29 Thompson Peter A. Director Conversion +114,039 114,039
2020-09-29 Thompson Peter A. Director Conversion · Series A Preferred Stock −4,025,076 0
2020-09-29 Thompson Peter A. Director Conversion · Series B Preferred Stock −1,076,891 0
2020-09-29 Thompson Peter A. Director Conversion · Series C Preferred Stock −518,191 0
2020-09-29 Thompson Peter A. Director Conversion · Series D Preferred Stock −380,133 0
2020-09-29 Thompson Peter A. Director Conversion · Series D Preferred Stock −114,039 0
2020-09-25 Thompson Peter A. Director Purchase +475,000 $18.00 $8.6M 475,000
2020-09-25 Thompson Peter A. Director Purchase +475,000 $18.00 $8.6M 475,000

Page 1 of 1 · 13 trades